Ibuprofeno B.Braun (Ibuprofen)

Ibuprofeno B.Braun, an intravenous NSAID, is indicated for several acute pain and fever pathways.

• Mild to moderate pain: provides rapid analgesia for conditions such as musculoskeletal injury.
• Postoperative pain: reduces pain intensity after surgical procedures.
• Fever: lowers elevated body temperature in adults.
• Inflammatory conditions: alleviates inflammation associated with flare‑ups of rheumatic diseases.

• Ibuprofen exerts its effect by reversibly inhibiting cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, which blocks the conversion of arachidonic acid to prostaglandins. The reduction in prostaglandin synthesis diminishes peripheral sensitisation of nociceptors, lowers the hypothalamic set‑point for temperature, and decreases inflammatory exudate formation, resulting in analgesic, antipyretic, and anti‑inflammatory actions.

Intravenous ibuprofen may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Nausea: mild stomach upset occurring shortly after infusion.
• Headache: transient headache during or after administration.
• Injection site reaction: erythema or discomfort at the infusion site.
• Dizziness: light‑headed feeling, especially with rapid infusion.

Serious or Rare Side Effects

• Gastrointestinal bleeding: severe bleeding in the stomach or intestines.
• Renal impairment: sudden decrease in kidney function, indicated by reduced urine output.
• Severe allergic reaction: anaphylaxis or angioedema requiring immediate medical attention.
• Hepatic dysfunction: elevated liver enzymes or hepatitis.

Prior to initiating therapy with Ibuprofeno B.Braun, clinicians should consider several safety measures.

• Assess renal function: evaluate creatinine clearance to avoid nephrotoxicity.
• Monitor hepatic status: check liver enzymes in patients with pre‑existing liver disease.
• Use lowest effective dose: limit exposure to reduce risk of adverse events.
• Avoid in known hypersensitivity: contraindicated for patients allergic to ibuprofen or other NSAIDs.
• Caution in cardiovascular disease: consider increased risk of thrombotic events.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ibuprofeno B.Braun can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): heightened risk of bleeding.
• Other NSAIDs or aspirin: additive gastrointestinal toxicity.
• ACE inhibitors or ARBs: may reduce renal perfusion and function.
• Lithium: increased lithium serum concentrations.
• Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely)

• Diuretics: potential for reduced renal function.
• Corticosteroids: increased risk of gastrointestinal ulceration.
• Antihypertensives: possible attenuation of blood pressure control.
• SSRIs: modest increase in bleeding risk.
• Cyclosporine: may enhance nephrotoxic effects.